Skip to content
Malathion
Ovide (malathion) is a small molecule pharmaceutical. Malathion was first approved as Ovide on 1982-08-02. It is used to treat lice infestations in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Malathion
Tradename
Company
Number
Date
Products
OVIDETaro PharmaceuticalN-018613 DISCN1982-08-02
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
malathionANDA2020-01-01
ovideANDA2018-07-20
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
lice infestationsD010373B85.2
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Malathion, Ovide, Taro
75604452027-02-01DS, DPU-986
79773242026-08-14DP
ATC Codes
P: Antiparasitic products, insecticides and repellents
P03: Ectoparasiticides, incl. scabicides, insecticides and repellents
P03A: Ectoparasiticides, incl. scabicides
P03AX: Other ectoparasiticides, incl. scabicides in atc
P03AX03: Malathion
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMALATHION
INN
Description
Diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate is a diester that is diethyl succinate in which position 2 is substituted by a (dimethoxyphosphorothioyl)thio group. It is a diester, an ethyl ester and an organic thiophosphate.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
Identifiers
PDB
CAS-ID121-75-5
RxCUI6606
ChEMBL IDCHEMBL1200468
ChEBI ID6651
PubChem CID4004
DrugBankDB00772
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 6,559 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
35 adverse events reported
View more details